Ardelyx (ARDX) Non Operating Income (2014 - 2026)
Ardelyx (ARDX) reported Non Operating Income of $2.1 million for Q1 2026, down 9.2% on a YoY basis from $2.3 million in Q1 2025, and up 1.64% quarter-over-quarter from $2.1 million in Q4 2025.
Ardelyx (ARDX) Non Operating Income (2014 - 2026) Analysis & Trends
Ardelyx has reported Non Operating Income for 13 years, with the latest figure at $2.1 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 9.2% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $8.5 million (down 6.88% YoY), and the FY2025 full-year result was $8.7 million, down 4.68% from the prior year.
- Non Operating Income for Q1 2026 stood at $2.1 million, up from $2.1 million in the prior quarter.
- The five-year high for Non Operating Income was $2.4 million in Q3 2025, with the low at $70000.0 in Q2 2022.
- Historically, Non Operating Income has averaged $1.7 million across 5 years, with a median of $2.1 million in 2025.
- Annual changes were most pronounced in 2022 — Non Operating Income plunged 91.74% — and 2023, when it surged 2108.57%.
- Ardelyx's Non Operating Income stood at $375000.0 in 2022, then jumped by 519.2% to $2.3 million in 2023, then advanced by 3.7% to $2.4 million in 2024, then decreased by 13.7% to $2.1 million in 2025, then increased by 1.64% to $2.1 million in 2026.
- The last three Non Operating Income figures came in at $2.1 million (Q1 2026), $2.1 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.11 Mn |
| Dec 31, 2025 | 2.08 Mn |
| Sep 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Mar 31, 2025 | 2.33 Mn |
| Dec 31, 2024 | 2.41 Mn |
| Sep 30, 2024 | 2.28 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Dec 31, 2023 | 2.32 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 375,000.00 |
| Sep 30, 2022 | 704,000.00 |
| Jun 30, 2022 | 70,000.00 |
| Mar 31, 2022 | 484,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Sep 30, 2021 | -134,000.00 |
| Jun 30, 2021 | 847,000.00 |